DENND1C | DENN/MADD domain containing 1C | | | | | | Mixed |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | | | | Group enriched |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
CD209 | CD209 molecule | CD markers Predicted membrane proteins
| | | | | Mixed |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
MAP2K7 | Mitogen-activated protein kinase kinase 7 | Enzymes Plasma proteins
| | | | | Expressed in all |
TIMM44 | Translocase of inner mitochondrial membrane 44 homolog (yeast) | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ELAVL1 | ELAV like RNA binding protein 1 | Plasma proteins
| | | | | Expressed in all |
MARCH2 | Membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Expressed in all |
HNRNPM | Heterogeneous nuclear ribonucleoprotein M | Plasma proteins
| | | | | Expressed in all |
MBD3L1 | Methyl-CpG binding domain protein 3-like 1 | | | | | | Group enriched |
MUC16 | Mucin 16, cell surface associated | Predicted membrane proteins
| | | | | Tissue enhanced |
COL5A3 | Collagen, type V, alpha 3 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
EIF3G | Eukaryotic translation initiation factor 3, subunit G | Plasma proteins
| | | | | Expressed in all |
DNMT1 | DNA (cytosine-5-)-methyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Transcription factors
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM5 | Intercellular adhesion molecule 5, telencephalin | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
RAVER1 | Ribonucleoprotein, PTB-binding 1 | | | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CDC37 | Cell division cycle 37 | Cancer-related genes
| | | | | Expressed in all |
KRI1 | KRI1 homolog (S. cerevisiae) | | | | | | Expressed in all |
CDKN2D | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | | | | | | Expressed in all |
ILF3 | Interleukin enhancer binding factor 3, 90kDa | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
DNM2 | Dynamin 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
TMED1 | Transmembrane emp24 protein transport domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PRKCSH | Protein kinase C substrate 80K-H | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ELAVL3 | ELAV like neuron-specific RNA binding protein 3 | | | | | | Tissue enriched |
ECSIT | ECSIT signalling integrator | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
CNN1 | Calponin 1, basic, smooth muscle | Cancer-related genes Cytoskeleton related proteins
| | | | | Tissue enhanced |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ZNF799 | Zinc finger protein 799 | Transcription factors
| | | | | Mixed |
ZNF443 | Zinc finger protein 443 | Transcription factors
| | | | | Mixed |
ZNF709 | Zinc finger protein 709 | Transcription factors
| | | | | Tissue enhanced |
MAN2B1 | Mannosidase, alpha, class 2B, member 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
DHPS | Deoxyhypusine synthase | Enzymes Plasma proteins
| | | | | Expressed in all |
TNPO2 | Transportin 2 | | | | | | Expressed in all |
ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Transporters
| | | | | Expressed in all |
HOOK2 | Hook microtubule-tethering protein 2 | | | | | | Expressed in all |
JUNB | Jun B proto-oncogene | Plasma proteins Transcription factors
| | | | | Expressed in all |
PRDX2 | Peroxiredoxin 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
RTBDN | Retbindin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNASE2 | Deoxyribonuclease II, lysosomal | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
GCDH | Glutaryl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
SYCE2 | Synaptonemal complex central element protein 2 | | | | | | Tissue enriched |
FARSA | Phenylalanyl-tRNA synthetase, alpha subunit | Enzymes
| | | | | Expressed in all |
RAD23A | RAD23 homolog A (S. cerevisiae) | Cancer-related genes
| | | | | Expressed in all |